반응식
[CH2:1]([C:3]1[CH:35]=[CH:34][C:6]([CH2:7][NH:8][CH:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][N:17]3[C:26]4[C:21](=[CH:22][CH:23]=[C:24]([O:27][CH3:28])[CH:25]=4)[C:20]([C:29]([NH:31][CH3:32])=[O:30])=[CH:19][C:18]3=[O:33])[CH2:11][CH2:10]2)=[CH:5][CH:4]=1)[CH3:2].[ClH:36].C(OCC)(=O)C>CO>[ClH:36].[CH2:1]([C:3]1[CH:35]=[CH:34][C:6]([CH2:7][NH:8][CH:9]2[CH2:10][CH2:11][N:12]([CH2:15][CH2:16][N:17]3[C:26]4[C:21](=[CH:22][CH:23]=[C:24]([O:27][CH3:28])[CH:25]=4)[C:20]([C:29]([NH:31][CH3:32])=[O:30])=[CH:19][C:18]3=[O:33])[CH2:13][CH2:14]2)=[CH:5][CH:4]=1)[CH3:2]참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
To 2 mL of a methanol solution containing 0.14 g of 1-(2-(4-(4-ethylbenzylamino)piperidin-1-yl)ethyl)-7-methoxy-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide, 1 mL of 4 mol/L hydrogen chloride/ethyl acetate was added at room temperature, and the solvent was removed under reduced pressure. Ethyl acetate was added to the residue thus obtained, and the resulting solid was filtered to give 0.15 g of 1-(2-(4-(4-ethylbenzylamino)piperidin-1-yl)ethyl)-7-methoxy-N-methyl-2-oxo-1,2-dihydroquinoline-4-carboxamide hydrochloride as a pale yellow solid.
후처리
- additionwas added at room temperature
- customthe solvent was removed under reduced pressure
- additionEthyl acetate was added to the residue
- customthus obtained
- filtrationthe resulting solid was filtered
출처 및 근거
- ORD 기록
- ord-4e3a52c7dc1144b5993f9b39d3a77104
- 출처 데이터셋
- uspto-grants-2013_09
- 특허 번호
- US08524738B2
연결된 노트
불러오는 중…